Is Maxlinear Inc (MXL) a risky stock?
As of July 27, 2026, Clavix grades Maxlinear Inc (MXL) F for risk, a composite score of 38 out of 100 on an A+ to F scale, which puts MXL in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
MXL price, last 3 months
MXL's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind MXL's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how MXL scores on each, as of July 27, 2026.
What's moving MXL's risk right now
Company-specific signals Clavix flags behind MXL's current grade, drawn from recent news and filings as of July 27, 2026.
MaxLinear raised its near-term outlook after Q2 results, with revenue growth led by optical AI data center products. Needham then set a $100 price target, about 67% above the prior level.
ClearBridge highlighted MaxLinear as a way to play rising AI transceiver demand, adding institutional support to the story. A routine July 8-K filing was also made with no flagged concerns.
An rating raised MaxLinear's price target to $100, roughly 67% above the previous level. The bump signals stronger confidence in the company's near-term growth trajectory.
Recent MXL news
The latest headlines Clavix ingested for Maxlinear Inc, newest first. These feed the news-sentiment dimension of MXL's grade.
What a F grade means
On the Clavix A+ to F scale, MXL's composite of 38 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell MXL or any security. Grades are risk indicators, not predictions of return. Data may be delayed.